{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:13:42Z","timestamp":1780917222601,"version":"3.54.1"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["102807"],"award-info":[{"award-number":["102807"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The prevalence of antibodies to Strongyloides stercoralis was measured in 0\u201312-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (P\u2005=\u2005.019), demonstrating collateral benefits of ivermectin MDA in this setting.<\/jats:p>","DOI":"10.1093\/cid\/ciaa584","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T09:01:56Z","timestamp":1589274116000},"page":"3226-3228","source":"Crossref","is-referenced-by-count":14,"title":["Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to\n                    <i>Strongyloides stercoralis<\/i>\n                    in Children"],"prefix":"10.1093","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-4743","authenticated-orcid":false,"given":"Michael","family":"Marks","sequence":"first","affiliation":[{"name":"Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom"},{"name":"Hospital for Tropical Diseases, University College London Hospitals NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gwyn","sequence":"additional","affiliation":[{"name":"Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Toloka","sequence":"additional","affiliation":[{"name":"Atoifi Adventist Hospital, Atoifi, Malaita Province, Solomon Islands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kositz","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Asugeni","sequence":"additional","affiliation":[{"name":"Atoifi Adventist Hospital, Atoifi, Malaita Province, Solomon Islands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena","family":"Asugeni","sequence":"additional","affiliation":[{"name":"Atoifi Adventist Hospital, Atoifi, Malaita Province, Solomon Islands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Diau","sequence":"additional","affiliation":[{"name":"Atoifi Adventist Hospital, Atoifi, Malaita Province, Solomon Islands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M","family":"Kaldor","sequence":"additional","affiliation":[{"name":"Kirby Institute, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Romani","sequence":"additional","affiliation":[{"name":"Kirby Institute, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Redman-MacLaren","sequence":"additional","affiliation":[{"name":"College of Medicine and Dentistry, James Cook University, Cairns, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"MacLaren","sequence":"additional","affiliation":[{"name":"College of Medicine and Dentistry, James Cook University, Cairns, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W","family":"Solomon","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom"},{"name":"Hospital for Tropical Diseases, University College London Hospitals NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C W","family":"Mabey","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom"},{"name":"Hospital for Tropical Diseases, University College London Hospitals NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C","family":"Steer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Melbourne, Melbourne, Australia"},{"name":"Department of General Medicine, Royal Children\u2019s Hospital, Melbourne, Australia"},{"name":"Tropical Diseases Research Group, Murdoch Children\u2019s Research Institute, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"2021012201434168300_CIT0001","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0065-308X(08)60036-6","article-title":"Human strongyloidiasis","volume":"38","author":"Grove","year":"1996","journal-title":"Adv Parasitol"},{"key":"2021012201434168300_CIT0002","doi-asserted-by":"crossref","first-page":"e0004051","DOI":"10.1371\/journal.pntd.0004051","article-title":"African program for onchocerciasis control 1995\u20132010: impact of annual ivermectin mass treatment on off-target infectious diseases","volume":"9","author":"Krotneva","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2021012201434168300_CIT0003","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(18)30790-4","article-title":"Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial","volume":"19","author":"Romani","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021012201434168300_CIT0004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-6851(02)00214-1","article-title":"Characterization of a recombinant immunodiagnostic antigen (NIE) from Strongyloides stercoralis L3-stage larvae","volume":"125","author":"Ravi","year":"2002","journal-title":"Mol Biochem Parasitol"},{"key":"2021012201434168300_CIT0005","doi-asserted-by":"crossref","first-page":"e0003491","DOI":"10.1371\/journal.pntd.0003491","article-title":"Accuracy of five serologic tests for the follow up of Strongyloides stercoralis infection","volume":"9","author":"Buonfrate","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2021012201434168300_CIT0006","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4269\/ajtmh.17-0725","article-title":"Impact of enhanced health interventions for United States-bound refugees: evaluating best practices in migration health","volume":"98","author":"Mitchell","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2021012201434168300_CIT0007","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/cid\/ciy574","article-title":"Randomized trial of community treatment with azithromycin and ivermectin mass drug administration for control of scabies and impetigo","volume":"68","author":"Marks","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021012201434168300_CIT0008","doi-asserted-by":"crossref","first-page":"e0005607","DOI":"10.1371\/journal.pntd.0005607","article-title":"Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community","volume":"11","author":"Kearns","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2021012201434168300_CIT0009","doi-asserted-by":"crossref","first-page":"e0004150","DOI":"10.1371\/journal.pntd.0004150","article-title":"Mass administration of ivermectin for the elimination of onchocerciasis significantly reduced and maintained low the prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador","volume":"9","author":"Anselmi","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2021012201434168300_CIT0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5365\/wpsar.2015.6.1.016","article-title":"Prevalence of soil-transmitted helminths in remote villages in East Kwaio, Solomon Islands","volume":"6","author":"Harrington","year":"2015","journal-title":"Western Pac Surveill Response J"},{"key":"2021012201434168300_CIT0011","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1473-3099(19)30289-0","article-title":"Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial","volume":"19","author":"Buonfrate","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021012201434168300_CIT0012","doi-asserted-by":"crossref","first-page":"e0005030","DOI":"10.1371\/journal.pntd.0005030","article-title":"Preclinical study of single-dose moxidectin, a new oral treatment for scabies: efficacy, safety, and pharmacokinetics compared to two-dose ivermectin in a porcine model","volume":"10","author":"Bernigaud","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2021012201434168300_CIT0013","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/cid\/cix278","article-title":"Efficacy of moxidectin versus ivermectin against strongyloides stercoralis infections: a randomized, controlled noninferiority trial","volume":"65","author":"Barda","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa584\/33783759\/ciaa584.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/12\/3226\/35936303\/ciaa584.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/12\/3226\/35936303\/ciaa584.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T23:54:11Z","timestamp":1611359651000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/71\/12\/3226\/5839773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":13,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,5,18]]},"published-print":{"date-parts":[[2020,12,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa584","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2019.12.18.19015248","asserted-by":"object"}]},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,15]]},"published":{"date-parts":[[2020,5,18]]}}}